Comorbidity of schizophrenia and cancer: Clinical recommendations for treatment

Psychiatria Danubina

Volumn 18, Issue 1-2, 2006, Pages 55-60

  Damjanović, Aleksandar ^a   Ivković, Maja ^a   Jašović Gašić, Miroslava ^a   Paunović, Vladimir ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cancer; Co morbidity; Schizophrenia; Treatment

Indexed keywords

ANTHRACYCLINE; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; CYCLOPHOSPHAMIDE; DIPHENHYDRAMINE; DOCETAXEL; DOPAMINE RECEPTOR BLOCKING AGENT; DULOXETINE; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; MAPROTILINE; NEUROLEPTIC AGENT; OLANZAPINE; PACLITAXEL; PAROXETINE; PHENOTHIAZINE; PIMOZIDE; PROLACTIN; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; TAMOXIFEN; UNINDEXED DRUG; VINCA ALKALOID;

AGRANULOCYTOSIS; ALCOHOL ABUSE; ARTICLE; BREAST CANCER; CANCER; CANCER RISK; COMORBIDITY; DRUG ANTAGONISM; DRUG METABOLISM; DRUG USE; ENDOMETRIUM CANCER; EPIDEMIOLOGICAL DATA; HUMAN; HYPERPROLACTINEMIA; MULTIPARA; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RISK ASSESSMENT; SCHIZOPHRENIA; TOBACCO DEPENDENCE;

EID: 33746119113     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Allison D, Fontaine R et al: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60:215-220.
2. Cohen M. Dembling B. Schorling J: The association between schizophrenia and cancer: a population-based mortality study. Schizophrenia Res 2002; 57:139-146
3. Coodin S: Body mass index in persons with schizophrenia. Can J Psych 2001; 46:549-555.
4. Csatary K: Chlorpromazines and cancer. Lancet 1972; 2:338-339.
5. Damjanović A, Ivković M, Jašović-Gašić M, Paunovic VR: Evaluation of risperidone mutagenic action by sister chromatide exchange test. Eur. J. Psychopharmacol 2003; 13(suppl 4): P.6.010.
6. Damjanović A: Sister chromatide exchange - SCE test in thepatients with schizophrenia. Master thesis. Belgrade 1992.
7. De Leon J, Becon E et al: The association between high nicotin dependence and severe mental illness may be consistent across countries. J Clin Psych 2002; 160:215-220.
8. Iishi H. et al: Inhibition by the dopaminergic antagonist haloperidole of experimental carcinogenesis induced by azoxymethane in rat colon. Cancer Res 1991; 51:6150-6152.
9. Kataoka Y, et al: Reversal of vinblastine resistance in human leucemic cells by haloperidol and dihydrohaloperidol. Biol Pharm Bull 2001; 24:612-617.
10. Lichterman D. Eklund J, Pukala S. et al: Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psych 2001; 58:573-578.
11. Margoles C. et al: Drug and alcohol use among the patients with schizophrenia and related psychosis: levels and consequencies. Schizophrenia Reser 2004; 67:157-166.
12. Mortensen P: Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psych Scand 1987; 75:585-590.
13. Pal J, Sarno A: Effect of risperidone on prolactinoma growth in a psychotic women. Psychosom Medic 2000; 62:736-738.
14. Perkins D: Treating schizophrenia in patients with cancer. In: Schizophrenia. The Clinical Guide to Pharmacotherapy for Patients with Co-occuring Medical Conditions. Nasrallah H. Dewan N. Keck P. (eds), University of Cincinnati, USA 2005; 10: 1-11.
15. Philips P, Johnson S: How does drug and alchocol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol 2001; 36:296-276.
16. Theisen F, Linden A, Geller F. et al: Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J Psych Res 2002; 35:339-345.
17. Vanable P, Carey M.: Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Adict Behav 2003; 17:259-265.
18. Wang P. et al: Dopamine antagonists and the development of breast cancer. Arch Gen Psych 2002; 59:1147-1154.
19. Yamazava K. Seki H: A case-controle study of endometrial cancer after antipsychotic exposure in premenopausal women. Oncology, 2003; 64:116-123.